CSF and blood samples from each participant were collected at a single session at approximately 8 am following overnight fasting as previously described.5 (link),30 (link) Concentrations of CSF Aβ40, Aβ42, t-tau, and p-tau181 were measured by chemiluminescent enzyme immunoassay using a fully automated platform (LUMIPULSE G1200; Fujirebio). CSF NfL was measured via commercial ELISA kit (UMAN Diagnostics). Plasma Aβ42 and Aβ40 were measured in the C2N Diagnostics commercial laboratory with the PrecivityAD immunoprecipitation–mass spectrometry assay.16 (link) Plasma p-tau181 and p-tau231 were measured in the Clinical Neurochemistry Laboratory, University of Gothenburg, using in-house Single molecule array (Simoa) assays on an HD-X analyzer (Quanterix), as previously described.19 (link),23 (link) Plasma NfL was measured with Quanterix Nf-Light assay kits at Washington University on a HD-X analyzer. All assays were performed by personnel who were blind to participant information.